The risk or severity of adverse effects can be increased when alprazolam is combined with tiagabine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when lidocaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when secobarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when clozapine is combined with benzocaine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with methotrexate.


The risk or severity of adverse effects can be increased when olanzapine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nicergoline is combined with diazepam.


The risk or severity of adverse effects can be increased when clorazepate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when clozapine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with butalbital.


The risk or severity of adverse effects can be increased when clorazepate is combined with Remoxipride.


The risk or severity of adverse effects can be increased when topiramate is combined with desipramine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Tadalafil.


The risk or severity of adverse effects can be increased when clozapine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when nicergoline is combined with pergolide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Eprosartan.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with quetiapine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Conivaptan.


The risk or severity of adverse effects can be increased when Etidocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Etidocaine is combined with promethazine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with sertraline.


The risk or severity of adverse effects can be increased when thiothixene is combined with clomipramine.


The risk or severity of adverse effects can be increased when cabergoline is combined with desipramine.


The risk or severity of adverse effects can be increased when clozapine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when meperidine is combined with lidocaine.


The risk or severity of adverse effects can be increased when diltiazem is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when tolmetin is combined with loteprednol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with metoclopramide.


The risk or severity of adverse effects can be increased when tolmetin is combined with suprofen.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with doxepin.


The risk or severity of adverse effects can be increased when Pinaverium is combined with atorvastatin.


The risk or severity of adverse effects can be increased when calcium lactate is combined with Calcium acetate.


The risk or severity of adverse effects can be increased when Tixocortol is combined with donepezil.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nilvadipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Articaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Articaine is combined with promethazine.


The risk or severity of adverse effects can be increased when sertraline is combined with tiapride.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when thioridazine is combined with enalapril.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tofisopam.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when triamterene is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Flupentixol is combined with etizolam.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when mesoridazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when atenolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when atenolol is combined with nicotine.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Sacubitril is combined with penbutolol.


The risk or severity of adverse effects can be increased when griseofulvin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when minoxidil is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Olopatadine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when amobarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with zaleplon.


The risk or severity of adverse effects can be increased when brimonidine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when benzocaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when pravastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with nimesulide.


The risk or severity of adverse effects can be increased when Trospium is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when midazolam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with triamterene.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with irbesartan.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with felodipine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Melatonin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Melatonin is combined with amisulpride.


The risk or severity of adverse effects can be increased when valsartan is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when trazodone is combined with Vilazodone.


The risk or severity of adverse effects can be increased when codeine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with orphenadrine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with prazepam.


The risk or severity of adverse effects can be increased when procarbazine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with dexamethasone.


The risk or severity of adverse effects can be increased when procarbazine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with spironolactone.


The risk or severity of adverse effects can be increased when THYMOL is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when meprobamate is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Isometheptene.


The risk or severity of adverse effects can be increased when meprobamate is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Iloperidone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when bifonazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when meprobamate is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with clonidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with thioridazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when thalidomide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with felodipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Uramustine.


The risk or severity of adverse effects can be increased when Metixene is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Fospropofol is combined with clonazepam.


The risk or severity of adverse effects can be increased when quazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when quazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with ethotoin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with felbamate.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when bupropion is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Propiverine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when rapamycin is combined with fosinopril.


The risk or severity of adverse effects can be increased when bifonazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when mirtazapine is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when Asenapine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Apremilast.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Articaine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with TEMOPORFIN.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Dothiepin.


The risk or severity of adverse effects can be increased when bumetanide is combined with metrizamide.


The risk or severity of adverse effects can be increased when Tramadol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Naftifine.


The risk or severity of adverse effects can be increased when brimonidine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when tolazoline is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when brimonidine is combined with methazolamide.


The risk or severity of adverse effects can be increased when propofol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Aliskiren.


The risk or severity of adverse effects can be increased when thioridazine is combined with tiapride.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Amrinone.


The risk or severity of adverse effects can be increased when carprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with difluprednate.


The risk or severity of adverse effects can be increased when amcinonide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when reserpine is combined with methadone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with zotepine.


The risk or severity of adverse effects can be increased when zotepine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when tolazoline is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when clidinium is combined with levodopa.


The risk or severity of adverse effects can be increased when Pramocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when Artemether is combined with barnidipine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when suprofen is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when sotalol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when HEROIN is combined with Normethadone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when thiothixene is combined with proparacaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Halazepam.


The risk or severity of adverse effects can be increased when clemastine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Normethadone.


The risk or severity of adverse effects can be increased when chloroquine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when quazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when nortriptyline is combined with tiagabine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with nalbuphine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with oxazepam.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Butethal is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when gabapentin is combined with HEROIN.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when pirenzepine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when buspirone is combined with triprolidine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when buspirone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pimozide is combined with Etidocaine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with hydralazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when HEROIN is combined with polythiazide.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Etomidate is combined with nefazodone.


The risk or severity of adverse effects can be increased when methadone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with pravastatin.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with dexamethasone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nadolol.


The risk or severity of adverse effects can be increased when levorphanol is combined with moclobemide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when carisoprodol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when fosinopril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when levorphanol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with furosemide.


The risk or severity of adverse effects can be increased when glutethimide is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with tizanidine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with SAQUINAVIR.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when phenazopyridine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when reserpine is combined with Perospirone.


The risk or severity of adverse effects can be increased when sotalol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with diflunisal.


The risk or severity of adverse effects can be increased when perphenazine is combined with protriptyline.


The risk or severity of adverse effects can be increased when perphenazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when minoxidil is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Bortezomib is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with haloperidol.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when dantrolene is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with alclofenac.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when loratadine is combined with felbamate.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when olanzapine is combined with gabapentin.


The risk or severity of adverse effects can be increased when butalbital is combined with sertraline.


The risk or severity of adverse effects can be increased when lisinopril is combined with meperidine.


The risk or severity of adverse effects can be increased when suprofen is combined with antipyrine.


The risk or severity of adverse effects can be increased when metaraminol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with dacarbazine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with temozolomide.


The risk or severity of adverse effects can be increased when Paliperidone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when scopolamine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when methysergide is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with meclizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when nicergoline is combined with ceritinib.


The risk or severity of adverse effects can be increased when flumethasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when ethanol is combined with Eluxadoline.


The risk or severity of adverse effects can be increased when moclobemide is combined with bezafibrate.


The risk or severity of adverse effects can be increased when flurazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when risperidone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Miltefosine is combined with barnidipine.


The risk or severity of adverse effects can be increased when morphine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Tramadol.


The risk or severity of adverse effects can be increased when Treprostinil is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Droxicam.


The risk or severity of adverse effects can be increased when busulfan is combined with ifosfamide.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with methocarbamol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with spironolactone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with triprolidine.


The risk or severity of adverse effects can be increased when brimonidine is combined with papaverine.


The risk or severity of adverse effects can be increased when levorphanol is combined with theobromine.


The risk or severity of adverse effects can be increased when nadolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when baclofen is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with bromocriptine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with primidone.


The risk or severity of adverse effects can be increased when zotepine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when zotepine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when pimozide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with nimesulide.


The risk or severity of adverse effects can be increased when ketoprofen is combined with formestane.


The risk or severity of adverse effects can be increased when leflunomide is combined with salicylamide.


The risk or severity of adverse effects can be increased when morphine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with triamcinolone.


The risk or severity of adverse effects can be increased when imipramine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with alclometasone.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with nitric oxide.


The risk or severity of adverse effects can be increased when tolazoline is combined with triamterene.


The risk or severity of adverse effects can be increased when procyclidine is combined with quinidine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when risperidone is combined with nalbuphine.


The risk or severity of adverse effects can be increased when risperidone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with trimipramine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when flurazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Perampanel is combined with citalopram.


The risk or severity of adverse effects can be increased when triamterene is combined with tizanidine.


The risk or severity of adverse effects can be increased when trazodone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when triamterene is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when moclobemide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when imipramine is combined with penbutolol.


The risk or severity of adverse effects can be increased when ethopropazine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Salsalate.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with doxorubicin.


The risk or severity of adverse effects can be increased when metolazone is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when Tramadol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with clozapine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with etodolac.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Metixene.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when risperidone is combined with thiopental.


The risk or severity of adverse effects can be increased when trandolapril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when risperidone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when lidocaine is combined with Halazepam.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with aspirin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when clidinium is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Almotriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when terbinafine is combined with eperisone.


The risk or severity of adverse effects can be increased when cabergoline is combined with vinorelbine.


The risk or severity of adverse effects can be increased when moclobemide is combined with risperidone.


The risk or severity of adverse effects can be increased when HEROIN is combined with imipramine.


The risk or severity of adverse effects can be increased when ethanol is combined with nefazodone.


The risk or severity of adverse effects can be increased when bepridil is combined with Nabilone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with prazepam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when bepridil is combined with sotalol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Articaine.


The risk or severity of adverse effects can be increased when HEROIN is combined with loratadine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when mirtazapine is combined with formoterol.


The risk or severity of adverse effects can be increased when trazodone is combined with methadone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when nifedipine is combined with terazosin.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when betaxolol is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Icatibant is combined with salicylamide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with promethazine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when cocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when hydromorphone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when ropinirole is combined with valsartan.


The risk or severity of adverse effects can be increased when hydromorphone is combined with quazepam.


The risk or severity of adverse effects can be increased when ondansetron is combined with dantrolene.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when oxycodone is combined with sulpiride.


The risk or severity of adverse effects can be increased when phenylephrine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when oxycodone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Bortezomib is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when carprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Bretylium is combined with terazosin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with felodipine.


The risk or severity of adverse effects can be increased when oxycodone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with irbesartan.


The risk or severity of adverse effects can be increased when selegiline is combined with Perospirone.


The risk or severity of adverse effects can be increased when furazolidone is combined with ritodrine.


The risk or severity of adverse effects can be increased when Nabilone is combined with sotalol.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when polythiazide is combined with digitoxin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with dipyridamole.


The risk or severity of adverse effects can be increased when clomipramine is combined with Riociguat.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when trandolapril is combined with epirizole.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when chloroquine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when sulconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when loxapine is combined with levorphanol.


The risk or severity of adverse effects can be increased when risperidone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when loxapine is combined with perphenazine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Normethadone is combined with theobromine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with acebutolol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with captopril.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when papaverine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with meperidine.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nicardipine.


The risk or severity of adverse effects can be increased when Levoleucovorin is combined with CAPECITABINE.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with pentazocine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when brimonidine is combined with citalopram.


The risk or severity of adverse effects can be increased when sevoflurane is combined with enalapril.


The risk or severity of adverse effects can be increased when selegiline is combined with sertraline.


The risk or severity of adverse effects can be increased when Masoprocol is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when midazolam is combined with amoxapine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Naftifine is combined with isradipine.


The risk or severity of adverse effects can be increased when propofol is combined with felbamate.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with topiramate.


The risk or severity of adverse effects can be increased when fludiazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when perphenazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with etizolam.


The risk or severity of adverse effects can be increased when propantheline is combined with orphenadrine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Droxicam.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when galanthamine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when linezolid is combined with rizatriptan.


The risk or severity of adverse effects can be increased when morniflumate is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when oxprenolol is combined with brotizolam.


The risk or severity of adverse effects can be increased when pentazocine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Flibanserin.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when morniflumate is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when acemetacin is combined with paramethasone.


The risk or severity of adverse effects can be increased when acemetacin is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when zaleplon is combined with meclizine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with pentazocine.


The risk or severity of adverse effects can be increased when brotizolam is combined with desipramine.


The risk or severity of adverse effects can be increased when ondansetron is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when clorazepate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with felbamate.


The risk or severity of adverse effects can be increased when benzphetamine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Dothiepin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with benazepril.


The risk or severity of adverse effects can be increased when hydralazine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when mepivacaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with medrysone.


The risk or severity of adverse effects can be increased when Trospium is combined with orphenadrine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when flumethasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Apremilast is combined with equilin.


The risk or severity of adverse effects can be increased when apraclonidine is combined with penbutolol.


The risk or severity of adverse effects can be increased when Normethadone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Normethadone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Tixocortol is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when SULFADOXINE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when meprobamate is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nicardipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Magaldrate is combined with misoprostol.


The risk or severity of adverse effects can be increased when meperidine is combined with HEROIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when sulindac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when phentolamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with teniposide.


The risk or severity of adverse effects can be increased when Isoconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when zotepine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with gemcitabine.


The risk or severity of adverse effects can be increased when protriptyline is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when oxymorphone is combined with amoxapine.


The risk or severity of adverse effects can be increased when mitoxantrone is combined with clozapine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with tiapride.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when methysergide is combined with pergolide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Articaine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with floctafenine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with prazosin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Mometasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Eplerenone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when codeine is combined with selegiline.


The risk or severity of adverse effects can be increased when acemetacin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when trandolapril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when triazolam is combined with prilocaine.


The risk or severity of adverse effects can be increased when methazolamide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when methazolamide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when chloroxine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when estazolam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with olanzapine.


The risk or severity of adverse effects can be increased when pentazocine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when nifedipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when pentazocine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when practolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Delavirdine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Pregabalin is combined with duloxetine.


The risk or severity of adverse effects can be increased when Torasemide is combined with netilmicin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when butabarbital is combined with thiothixene.


The risk or severity of adverse effects can be increased when rizatriptan is combined with promazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when methysergide is combined with Sorafenib.


The risk or severity of adverse effects can be increased when bromazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with DESONIDE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when oxycodone is combined with amisulpride.


The risk or severity of adverse effects can be increased when oxycodone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with protriptyline.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with methadone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with diltiazem.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with celiprolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with cetirizine.


The risk or severity of adverse effects can be increased when propofol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Asenapine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with norepinephrine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when felodipine is combined with papaverine.


The risk or severity of adverse effects can be increased when celecoxib is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when HEROIN is combined with clidinium.


The risk or severity of adverse effects can be increased when oxycodone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with diazepam.


The risk or severity of adverse effects can be increased when topiramate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when rizatriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when butabarbital is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when sumatriptan is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Pizotifen is combined with nefazodone.


The risk or severity of adverse effects can be increased when thiopental is combined with chlormezanone.


The risk or severity of adverse effects can be increased when cerulenin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when prazosin is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when meclizine is combined with felbamate.


The risk or severity of adverse effects can be increased when doxazosin is combined with D-mannitol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with indapamide.


The risk or severity of adverse effects can be increased when codeine is combined with cetirizine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Halazepam.


The risk or severity of adverse effects can be increased when mesoridazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with methazolamide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with proparacaine.


The risk or severity of adverse effects can be increased when prazosin is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with benazepril.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with sulpiride.


The risk or severity of adverse effects can be increased when Nepafenac is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when selegiline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when selegiline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with felbamate.


The risk or severity of adverse effects can be increased when Vecuronium is combined with levorphanol.


The risk or severity of adverse effects can be increased when selegiline is combined with promethazine.


The risk or severity of adverse effects can be increased when chloroquine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when clorazepate is combined with maprotiline.


The risk or severity of adverse effects can be increased when clorazepate is combined with mesoridazine.


The risk or severity of adverse effects can be increased when temazepam is combined with lidocaine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with formestane.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with penbutolol.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Butethal.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when rescinnamine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when difluprednate is combined with physostigmine.


The risk or severity of adverse effects can be increased when clorazepate is combined with tetracaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with benzocaine.


The risk or severity of adverse effects can be increased when difluprednate is combined with rivastigmine.


The risk or severity of adverse effects can be increased when halcinonide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Butoconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with terazosin.


The risk or severity of adverse effects can be increased when biperiden is combined with pirenzepine.


The risk or severity of adverse effects can be increased when Perampanel is combined with Milnacipran.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with dopamine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with fosinopril.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when azelastine is combined with acemetacin.


The risk or severity of adverse effects can be increased when nifedipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when dyclonine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when halcinonide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Olaparib is combined with oxycodone.


The risk or severity of adverse effects can be increased when ramipril is combined with leflunomide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with thiamylal.


The risk or severity of adverse effects can be increased when Demecarium is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when triazolam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when diclofenac is combined with leflunomide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ramipril is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when pergolide is combined with Lapatinib.


The risk or severity of adverse effects can be increased when ramipril is combined with indomethacin.


The risk or severity of adverse effects can be increased when Vecuronium is combined with topiramate.


The risk or severity of adverse effects can be increased when buspirone is combined with efavirenz.


The risk or severity of adverse effects can be increased when carprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when buspirone is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when celecoxib is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when haloperidol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when captopril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nicergoline is combined with Imatinib.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Normethadone.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with morphine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when tubocurarine is combined with nicotine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Phenelzine.


The risk or severity of adverse effects can be increased when tropicamide is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when amiodarone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when trimipramine is combined with formoterol.


The risk or severity of adverse effects can be increased when terconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when etodolac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with clemastine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when buspirone is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when buspirone is combined with gabapentin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with desipramine.


The risk or severity of adverse effects can be increased when meprobamate is combined with butamben.


The risk or severity of adverse effects can be increased when epoprostenol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when halothane is combined with clonazepam.


The risk or severity of adverse effects can be increased when halothane is combined with promethazine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when efavirenz is combined with promethazine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with phenytoin.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Conivaptan.


The risk or severity of adverse effects can be increased when perphenazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ondansetron is combined with halothane.


The risk or severity of adverse effects can be increased when estazolam is combined with procaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when felbamate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when midazolam is combined with butamben.


The risk or severity of adverse effects can be increased when estazolam is combined with trimipramine.


The risk or severity of adverse effects can be increased when thiamylal is combined with etizolam.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Nintedanib.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Lenvatinib.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with felodipine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with tibolone.


The risk or severity of adverse effects can be increased when prazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Olaparib.


The risk or severity of adverse effects can be increased when thiothixene is combined with brotizolam.


The risk or severity of adverse effects can be increased when pancuronium is combined with HEROIN.


The risk or severity of adverse effects can be increased when ketoprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with methyldopa.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when pentazocine is combined with maprotiline.


The risk or severity of adverse effects can be increased when nortriptyline is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when pentazocine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when quinapril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when temazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when thiopental is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with meclizine.


The risk or severity of adverse effects can be increased when brotizolam is combined with trimipramine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ketorolac is combined with fenoprofen.


The risk or severity of adverse effects can be increased when oxazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when oxazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when dexamethasone is combined with leflunomide.


The risk or severity of adverse effects can be increased when diazepam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when chloroxine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when gabapentin is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when gabapentin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when butalbital is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Melatonin is combined with Ramelteon.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Melatonin is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when Tramadol is combined with thiamylal.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when clorazepate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when enflurane is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with lisinopril.


The risk or severity of adverse effects can be increased when ipratropium is combined with meperidine.


The risk or severity of adverse effects can be increased when halothane is combined with atenolol.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with felodipine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with nabumetone.


The risk or severity of adverse effects can be increased when codeine is combined with Melatonin.


The risk or severity of adverse effects can be increased when indomethacin is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with ketorolac.


The risk or severity of adverse effects can be increased when Agomelatine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with tenoxicam.


The risk or severity of adverse effects can be increased when zopiclone is combined with Asenapine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when amifostine is combined with terazosin.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with alclofenac.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when amifostine is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when buspirone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when quinapril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with salicylic acid.


The risk or severity of adverse effects can be increased when zaleplon is combined with dantrolene.


The risk or severity of adverse effects can be increased when buspirone is combined with dyclonine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with quetiapine.


The risk or severity of adverse effects can be increased when morphine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when morphine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with carvedilol.


The risk or severity of adverse effects can be increased when morphine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when thioridazine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with hydralazine.


The risk or severity of adverse effects can be increased when prazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Cladribine.


The risk or severity of adverse effects can be increased when valsartan is combined with alclofenac.


The risk or severity of adverse effects can be increased when meperidine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with donepezil.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Salbutamol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with doxepin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when topiramate is combined with zonisamide.


The risk or severity of adverse effects can be increased when nabumetone is combined with acemetacin.


The risk or severity of adverse effects can be increased when thiothixene is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when clozapine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when atenolol is combined with propranolol.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Mometasone.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when procaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when rosiglitazone is combined with Treprostinil.


The risk or severity of adverse effects can be increased when tetracaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when lisinopril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with clofazimine.


The risk or severity of adverse effects can be increased when tetracaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when epinephrine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tolazoline is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when nadolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when isradipine is combined with benazepril.


The risk or severity of adverse effects can be increased when HEROIN is combined with furazolidone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with phentolamine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with furosemide.


The risk or severity of adverse effects can be increased when pergolide is combined with sertraline.


The risk or severity of adverse effects can be increased when tolmetin is combined with triamcinolone.


The risk or severity of adverse effects can be increased when thioridazine is combined with clidinium.


The risk or severity of adverse effects can be increased when pergolide is combined with pimozide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Pinaverium is combined with pravastatin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with quetiapine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ketamine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when terconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with metolazone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when pentazocine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when atenolol is combined with nimodipine.


The risk or severity of adverse effects can be increased when reserpine is combined with methazolamide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with nitric oxide.


The risk or severity of adverse effects can be increased when pentazocine is combined with pargyline.


The risk or severity of adverse effects can be increased when Micafungin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when methadone is combined with sumatriptan.


The risk or severity of adverse effects can be increased when proparacaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Asenapine is combined with clonidine.


The risk or severity of adverse effects can be increased when methadone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when ropinirole is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with equilin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with clonidine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with maprotiline.


The risk or severity of adverse effects can be increased when fenoprofen is combined with equilin.


The risk or severity of adverse effects can be increased when tetracaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nimodipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with salicylic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when oxprenolol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with felodipine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with benazepril.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with D-mannitol.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Nabilone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with antipyrine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ethanol is combined with aspirin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with estrone.


The risk or severity of adverse effects can be increased when tetracaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when tizanidine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Arotinolol is combined with metoprolol.


The risk or severity of adverse effects can be increased when rapamycin is combined with trandolapril.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Perospirone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nadolol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when DESONIDE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when reserpine is combined with propofol.


The risk or severity of adverse effects can be increased when nabumetone is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when sulconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ketoprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Lapatinib.


The risk or severity of adverse effects can be increased when codeine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with trandolapril.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when procarbazine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when clonidine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with betaxolol.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when resveratrol is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when resveratrol is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with metoclopramide.


The risk or severity of adverse effects can be increased when tolmetin is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Asenapine is combined with cocaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Pentolinium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when cilnidipine is combined with reserpine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when nifedipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with METAXALONE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when loteprednol is combined with ambenonium.


The risk or severity of adverse effects can be increased when ethopropazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when resveratrol is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when triazolam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when fosinopril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Idelalisib is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when Carbetocin is combined with tretinoin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with isoflurane.


The risk or severity of adverse effects can be increased when Lurasidone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Lurasidone.


The risk or severity of adverse effects can be increased when gabapentin is combined with Normethadone.


The risk or severity of adverse effects can be increased when Halazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with levorphanol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Icatibant.


The risk or severity of adverse effects can be increased when bromocriptine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when tropicamide is combined with meperidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when bromocriptine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when lidocaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with methazolamide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with amisulpride.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when loxapine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when doxycycline is combined with Isotretinoin.


The risk or severity of adverse effects can be increased when haloperidol is combined with butalbital.


The risk or severity of adverse effects can be increased when hydromorphone is combined with trimipramine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when nimesulide is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with thalidomide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with metaproterenol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with procaine.


The risk or severity of adverse effects can be increased when trazodone is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when Masoprocol is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when hydroxyurea is combined with didanosine.


The risk or severity of adverse effects can be increased when Calcifediol is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Pramocaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when etizolam is combined with desipramine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when brimonidine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with sertraline.


The risk or severity of adverse effects can be increased when furazolidone is combined with linezolid.


The risk or severity of adverse effects can be increased when phenytoin is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when flurazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with zaleplon.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with sertraline.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nimesulide is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when terconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when Propacetamol is combined with halcinonide.


The risk or severity of adverse effects can be increased when Propacetamol is combined with difluprednate.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when clozapine is combined with dyclonine.


The risk or severity of adverse effects can be increased when L-phenylalanine is combined with clozapine.


The risk or severity of adverse effects can be increased when promethazine is combined with thiopental.


The risk or severity of adverse effects can be increased when topiramate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when isoflurane is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when morphine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when triazolam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with bromazepam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with cetirizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with butamben.


The risk or severity of adverse effects can be increased when Lurasidone is combined with protriptyline.


The risk or severity of adverse effects can be increased when sumatriptan is combined with metoclopramide.